Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 3/2012

01-03-2012 | Original Research Paper

Study of dexamethasone, baicalin and octreotide on brain injury of rats with severe acute pancreatitis

Authors: Ou Jingmin, Zhang Xiping, Wang Chun, Yan Ping, Ye Qian

Published in: Inflammation Research | Issue 3/2012

Login to get access

Abstract

Objective

To investigate the protecting effects of dexamethasone (DXM), baicalin and octreotide on brain injury of rats with severe acute pancreatitis (SAP) and explore their underlying mechanism.

Methods

This experiment was divided into two different parts: (1) In the first part, 90 SAP rats were randomly divided into a model control group and a DXM treated group (n = 45, respectively). (2) In the second part, 135 SAP rats were randomly divided into a model control group, a baicalin treated group and an octreotide treated group (n = 45, respectively). In two different experiments, the same number of normal rats were considered as the sham-operated group (n = 45, respectively). At 3, 6 and 12 h after operation, the pathological changes in the brain were observed. The expression levels of nuclear factor-κB (NF-κB), Bax and Bcl-2 proteins were detected and apoptosis indexes were calculated, using brain tissue microarray section.

Results

(1) First part: The expression levels of Bax and Bcl-2 were significantly higher in the DXM treated group than those in the model control group at different time points, while the content of NF-κB protein and pathological changes were significantly lower in the treated group than those in the model control group (P < 0.05, P < 0.01 or P < 0.001). But the apoptotic indexes of brain tissue were not significantly different at different time points (P > 0.05). (2) Second part: At all time points after operation, the expression levels of NF-κB in the brain of treated groups were, to varying degrees, significantly lower than those in the model control group while the expression levels of Bcl-2 protein in baicalin and octreotide group were significantly higher than those in model control group (P < 0.01, P < 0.01 and P < 0.05, respectively). At 12 h after operation, the expression level of Bax protein in baicalin treated group was significantly higher than those in model control group and octreotide treated group (P < 0.05 and P < 0.01, respectively).

Conclusions

Dexamethasone, baicalin and octreotide can exert protective effects against brain injury in SAP rats mainly through inhibiting the expression of NF-κB protein.
Literature
1.
Zhang XP, Ye Q, Jiang XG, Ma ML, Zhu FB, Zhang RP, Cheng QH. Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis. World J Gastroenterol. 2007;13(34):4566–73.PubMed
2.
Lu XS, Qiu F, Li YX, Li JQ, Fan QQ, Zhou RG. Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis. Pancreas. 2010;39(4):516–9.PubMedCrossRef
3.
Zhang XP, Tian H. Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2007;6(2):134–40.PubMed
4.
Sun GH, Yang YS, Liu QS, Cheng LF, Huang XS. Pancreatic encephalopathy and Wernicke encephalopathy in association with acute pancreatitis: a clinical study. World J Gastroenterol. 2006;12(26):4224–7.PubMed
5.
Suzuki M, Shimizu T, Kudo T, Shoji H, Ohtsuka Y, Yamashiro Y. Octreotide prevents l-asparaginase-induced pancreatic injury in rats. Exp Hematol. 2008;36(2):172–80.PubMedCrossRef
6.
Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT. Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice. HPB (Oxford). 2010;12(6):403–11.CrossRef
7.
Xiping Z, Guanghua F, Jinxian H, Weihong W, Rujun X, Wei Z, Jing Y, Qijun Y, Meijuan Y, Qing W, Lini F. Baicalin protects thymus of rats with severe acute pancreatitis. Inflammation. 2010;33(3):157–65.PubMedCrossRef
8.
Liu X, Liu Q, Pan C. Early preventive treatment for severe acute pancreatitis combined with lung injury. Chin J Traumatol. 2002;5(3):190–2. In chinese.PubMed
9.
Ramudo L, Yubero S, Manso MA, Sanchez-Recio J, Weruaga E, De Dios I. Effects of dexamethasone on intercellular adhesion molecule 1 expression and inflammatory response in necrotizing acute pancreatitis in rats. Pancreas. 2010;39(7):1057–63.PubMedCrossRef
10.
Kandil E, Lin YY, Bluth MH, Zhang H, Levi G, Zenilman ME. Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins. World J Gastroenterol. 2006;12(42):6806–11.PubMed
11.
Xiping Z, Ruiping Z, Binyan Y, Li Z, Hanqing C, Wei Z, Rongchao Y, Jing Y, Wenqin Y, Jinjin B. Protecting effects of a large dose of dexamethasone on spleen injury of rats with severe acute pancreatitis. J Gastroenterol Hepatol. 2010;25(2):302–8.PubMedCrossRef
12.
Zhu H, Wang Z, Xing Y, Gao Y, Ma T, Lou L, Lou J, Gao Y, Wang S, Wang Y. Baicalin reduces the permeability of the blood–brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J Ethnopharmacol. 2011 Sep 3. (Epub ahead of print).
13.
Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models. Pulm Pharmacol Ther. 2010;23(5):411–9.PubMedCrossRef
14.
Zhang X, Tian H, Wu C, Ye Q, Jiang X, Chen L, Cai Y, Xu R, Yuan W. Effect of baicalin on inflammatory mediator levels and microcirculation disturbance in rats with severe acute pancreatitis. Pancreas. 2009;38(7):732–8.PubMedCrossRef
15.
Xue D, Zhang W, Zhang Y, Wang H, Zheng B, Shi X. Adjusting effects of baicalin for nuclear factor-kappaB and tumor necrosis factor-alpha on rats with caerulein-induced acute pancreatitis. Mediators Inflamm. 2006;2006(5):262–95.
16.
Luo XM, Han YM, Tang ZH, et al. Experimental studies on the protective effect of Baicalin on mouse brain. Chinese Journal of Traditional Medical Science and Technology. 2005;21(1):1–5 (In Chinese).
17.
Wang CY, Jiang YL, Zhi HY, et al. Protective effect of baicalin on brain injury. Chinese Traditional and Herbal Drugs. 2004;35:188–9 (In Chinese).
18.
Jia Y, Yang Y, Zhou Y, Song Y, Liu L, Song J, Wang X, Zhong L, Yu X. Differentiation of rat bone marrow stromal cells into neuron induced by baicalin. Zhonghua Yi Xue Za Zhi. 2002;82(19):1337–41. In Chinese.PubMed
19.
Heo HJ, Kim DO, Choi SJ, Shin DH, Lee CY. Potent Inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. J Agric Food Chem. 2004;52(13):4128–32.PubMedCrossRef
20.
Zhang XP, Zhang L, Yang P, Zhang RP, Cheng QH. Protective effects of baicalin and octreotide on multiple organ injury in severe acute pancreatitis. Dig Dis Sci. 2008;53(2):581–91.PubMedCrossRef
21.
Zhang XP, Zhang L, He JX, Zhang RP, Cheng QH, Zhou YF, Lu B. Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis. World J Gastroenterol. 2007;13(5):717–24.PubMed
22.
Zhang XP, Tian H, Lai YH, Chen L, Zhang L, Cheng QH, Yan W, Li Y, Li QY, He Q, Wang F. Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis. World J Gastroenterol. 2007;13(38):5079–89.PubMed
23.
Xiping Z, Hua T, Hanqing C, Li C, Zhiwei W, Keyi W, Wei Y, Yun L, Qingyu L, Qing H, Fei W. The protecting effects and mechanisms of Baicalin and Octreotide on heart injury in rats with SAP. Mediators Inflamm. 2007;2007:19469.PubMed
24.
Gomez G, Lee HM, He Q, Englander EW, Uchida T, Greeley GH Jr. Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp Biol Med (Maywood). 2001;226(7):692–700.
25.
Bonior J, Jaworek J, Kot M, Konturek SJ, Pawlik WW. Endotoxemia in the infant rats modulates HSP60 protein level in the pancreatic acinar cells. J Physiol Pharmacol. 2007;58(Suppl 3):189–98.PubMed
26.
Zhang XP, Chen L, Hu QF, Tian H, Xu RJ, Wang ZW, Wang KY, Cheng QH, Yan W, Li Y, Li QY, He Q, Wang F. Effects of large dose of dexamethasone on inflammatory mediators and pancreatic cell apoptosis of rats with severe acute pancreatitis. World J Gastroenterol. 2007;13(41):5506–11.PubMed
27.
Zhang XP, Zhang L, Wang Y, Cheng QH, Wang JM, Cai W, Shen HP, Cai J. Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. JOP. 2007;8(4):400–12.PubMed
28.
Zhang XP, Zhang L, Xu HM, Xu YP, Cheng QH, Wang JM, Shen HP. Application of tissue microarrays to study the influence of dexamethasone on NF-kappaB expression of pancreas in rat with severe acute pancreatitis. Dig Dis Sci. 2008;53(2):571–80.PubMedCrossRef
29.
Zhang X, Chen L, Luo L, Tian H, Feng G, Cai Y, Xu R, Wang K, Wang Z. Study of the protective effects of dexamethasone on ileum mucosa injury in rats with severe acute pancreatitis. Pancreas. 2008;37(3):e74–82.PubMedCrossRef
30.
Xiping Z, Li C, Miao L, Hua T. Protecting effects of dexamethasone on thymus of rats with severe acute pancreatitis. Mediators Inflamm. 2007;2007:723–61.
31.
Pavle G, Ana S, Sanja S, Dejan R, Nenad I, Aleksandar K, Nada P, Borivoje K, Stijak L, Branislav S, Zoran M, Djordje B. SIRS score on admission and initial concentration of IL-6 as severe acute pancreatitis outcome predictors. Hepatogastroenterology. 2010;57(98):349–53.PubMed
32.
Gong D, Zhang P, Ji D, Chen Z, Li W, Li J, Li L, Liu Z. Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: a preliminary report. Int J Artif Organs. 2010;33(1):22–9.PubMed
33.
Zhang XP, Tian H, Wu DJ, Feng GH, Chen L, Zhang J, Xu RJ, Cai Y, Ju TF, Xie Q. Pathological changes in multiple organs of rats with severe acute pancreatitis treated by baicalin and Octreotide. Hepatobiliary Pancreat Dis Int. 2009;8(1):85–92.PubMed
34.
Zhang X, Feng G, Weng W, Liang J, Lin N, Cai Y, Xu R, Zhou N, Yuan M, Yuan W, Xia X. Protective effects of baicalin and Octreotide on intestinal mucosa of rats with severe acute pancreatitis. Turk J Gastroenterol. 2009;20(2):108–15.PubMed
35.
Farkas G, Márton J, Nagy Z, Mándi Y, Takács T, Deli MA, Abrahám CS. Experimental acute pancreatitis results in increased blood–brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett. 1998;242(3):147–50.PubMedCrossRef
36.
Guo J, Huang ZW, Fan JY, Chen Y, He FQ. Risk factor analysis of severe acute pancreatitis complicated by pancreatic encephalopathy. Zhong Xi Yi Jie He Xue Bao. 2008;6(4):352–4.PubMedCrossRef
37.
Xiping Z, Jun F, Jie Z, Bingyan Y, Jing M, Wei Z, Jing Y, Penghui J, Wenqin Y, Ninnin Z, Jiao H. Influence of Dexamethasone on the expression levels of P-selectin protein in multiple organs of rats with severe acute pancreatitis. Inflamm Res. 2010;59(1):31–9.PubMedCrossRef
38.
Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang HG. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci. 1994;91(20):9238–42.PubMedCrossRef
39.
Gu JC, Wang Y, Zhang ZT, Xue JG, Li JS, Zhou YZ. Effects of human interleukin 10 gene transfer on the expression of Bcl-2 Bax and apoptosis of hepatocyte in rats with acute hemorrhagic necrotizing pancreatitis. Chin Med J (Engl). 2005;118(19):1658–60.
40.
Sugiyama Y, Kato S, Abe M, Mitsufuji S, Takeuchi K. Different effects of Dexamethasone and the nitric oxide synthase inhibitor L-NAME on caerulein-induced rat acute pancreatitis, depending on the severity. Inflammopharmacol. 2005;13(1–3):291–301.CrossRef
41.
Wang ZF, Pan CE, Lu Y, Liu SG, Zhang GJ, Zhang XB. The role of inflammatory mediators in severe acute pancreatitis and regulation of glucocorticoids. Hepatobiliary Pancreat Dis Int. 2003;2(3):458–62.PubMed
42.
Paszt A, Takács T, Rakonczay Z, et al. The role of the glucocorticoid-dependent mechanism in the progression of sodium taurocholate- induced acute pancreatitis in the rat. Pancreas. 2004;29(1):75–82.PubMedCrossRef
43.
Huang JH, Huang XH, Chen ZY, Zhen QS, Sun RY. Dose conversion among different animals and healthy volunteers in pharmacological study. Chin J Clinic Pharma Therapeut. 2004;9(9):1069–72. In Chinese.
44.
Srinivas NR. Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica. 2010;40(5):357–67.PubMedCrossRef
45.
Xue X, Qu XJ, Yang Y, Sheng XH, Cheng F, Jiang EN, Wang JH, Bu W, Liu ZP. Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. Biochem Biophys Res Commun. 2010;403(3–4):398–404.PubMedCrossRef
46.
Tu XK, Yang WZ, Liang RS, Shi SS, Chen JP, Chen CM, Wang CH, Xie HS, Chen Y, Ouyang LQ. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem Res. 2011 Jun 17.
47.
Li J, Wang R, Tang C. Somatostatin and octreotide on the treatment of acute pancreatitis - basic and clinical studies for three decades. Curr Pharm Des. 2011;17(16):1594–601.PubMedCrossRef
48.
Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, Li PM, Fan ZN, Sun WS, Shen YZ, Ma SR, Xie WF, Chen MH, Li YQ. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol. 2007;102(1):46–51.PubMedCrossRef
49.
Thomopoulos KC, Pagoni NA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc. 2006;64(5):726–31.PubMedCrossRef
50.
Rakonczay Z Jr, Hegyi P, Takács T, McCarroll J, Saluja AK. The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut. 2008;57(2):259–67.PubMedCrossRef
51.
Algül H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis and NF-kappaB/Rel activation. Pancreatology. 2002;2(6):503–9.PubMedCrossRef
Metadata
Title
Study of dexamethasone, baicalin and octreotide on brain injury of rats with severe acute pancreatitis
Authors
Ou Jingmin
Zhang Xiping
Wang Chun
Yan Ping
Ye Qian
Publication date
01-03-2012
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 3/2012
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0408-4

Other articles of this Issue 3/2012

Inflammation Research 3/2012 Go to the issue

Original Research Paper

The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair

Original Research Paper

Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells

Original Research Paper

Severe neutrophil-mediated lung inflammation in myeloperoxidase-deficient mice exposed to zymosan

Original Research Paper

Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats

Review

TLR4 polymorphisms and disease susceptibility

Original Research Paper

A20 and ABIN-3 possibly promote regression of trehalose 6,6′-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits